Nitric oxide and mitochondrial biogenesis in sepsis

脓毒症中的一氧化氮和线粒体生物发生

基本信息

  • 批准号:
    8534342
  • 负责人:
  • 金额:
    $ 31.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-23 至 2014-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This revised competitive renewal application seeks to understand how nitric oxide (NO) production in bacterial sepsis causes both mitochondrial damage and regulates mitochondrial quality control, which protects against organ failure. In the previous grant cycle, we discovered that toll-like receptor (TLR) activation of NF-kB- dependent NO synthase (iNOS/NOS2) is involved in the regulation of hepatic mitochondrial biogenesis through the major co-activator, PGC-11 and the adenosine monophosphate (AMP)-activated protein kinase (AMPK). Our preliminary data in mice with sepsis indicate that: NOS2 induction leads to AMPK activation, AMPK helps to activate mitochondrial biogenesis, but not always after ATP depletion, and NOS2 deficiency diminishes AMPK up-regulation and mitochondrial biogenesis and increases apoptosis and inflammation in response to TLR activation. Thus, AMPK appears to activate mitochondrial biogenesis while opposing apoptosis and inflammation in sepsis. In contrast, too much NO is independently associated with mitochondrial damage and loss of NO signal specificity by chemical attack of NO species (NOx) on proteins and nucleic acids. We hypothesize that NOS2, acting in part through AMPK, is required for apposite regulation of the transcriptional program of mitochondrial biogenesis before the failure of ATP production in order to maintain mitochondrial quality control and prevent cell death in sepsis. A test of this hypothesis requires definitions of NO-dependent transcriptional control mechanisms, the role of AMPK, and the chemical biology of mitochondrial NO in relevant model systems. Our approach will focus on the liver as a sentinel organ and on one genetic factor- NOS2- as a quantitative influence on mitochondrial turnover and cell survival. We plan to test these Specific Aims: Aim 1: To determine the role of NOS2 on hepatic mitochondrial biogenesis and cell survival during severe sepsis through quantitative NOS2 gene titration studies. 1A. Define the relationships between NOx-mediated mtDNA and protein damage, respiratory capacity, high-energy metabolite levels, and sepsis-induced hepatic cell death using NOS2 titration. 1B. Assess the importance of NOS2 expression on the regulation of mitochondrial biogenesis in sepsis through CREB and/or NRF-1 induction and regulation of NRF-21 (GABPA) and/or PGC-11 expression. Aim 2: To understand hepatic AMPK activation in sepsis in relation to NOS2, the transcriptional program of mitochondrial biogenesis, and prevention of apoptosis. 2A. Determine if NO-dependent AMPK activation promotes mitochondrial biogenesis in sepsis through CREB and/or prevents apoptosis by inhibitory phosphorylation of pro-apoptotic proteins, Bad and BNIP3. 2B. Determine if pharmacological activation of AMPK in sepsis can promote mitochondrial biogenesis and/or inhibit apoptosis independently of NOS2. These studies will provide new insights into NOx-induced mitochondrial damage in sepsis in the context of physiological mechanisms by which NOS2 regulates mitochondrial biogenesis and the extent to which it is orchestrated by AMPK. By implication, NO regulation of AMPK would play a critical salvage role in MODS, and this knowledge would allow rational new pharmacological approaches to support mitochondrial function while minimizing collateral damage by NOx.
描述(由申请人提供):此修订后的竞争性更新申请旨在了解细菌性脓毒症中一氧化氮(NO)的产生如何导致线粒体损伤并调节线粒体质量控制,从而防止器官衰竭。在之前的研究中,我们发现Toll样受体(TLR)激活NF-kB依赖的NO合酶(iNOS/NOS 2)通过主要的共激活因子PGC-11和腺苷酸(AMP)激活的蛋白激酶(AMPK)参与肝线粒体生物合成的调节。 我们在脓毒症小鼠中的初步数据表明:NOS 2诱导导致AMPK激活,AMPK有助于激活线粒体生物合成,但并不总是在ATP耗尽后,NOS 2缺乏减少AMPK上调和线粒体生物合成,并增加TLR激活引起的细胞凋亡和炎症。因此,AMPK似乎激活线粒体生物合成,同时对抗脓毒症中的细胞凋亡和炎症。相反,太多的NO与线粒体损伤和NO信号特异性的损失独立相关,NO物质(NOx)对蛋白质和核酸的化学攻击。我们推测,NOS 2,部分通过AMPK,需要适当的调节线粒体生物合成的转录程序之前,ATP生产失败,以保持线粒体质量控制和预防细胞死亡败血症。这一假设的测试需要定义NO依赖的转录控制机制,AMPK的作用,和线粒体NO在相关模型系统的化学生物学。我们的方法将集中在肝脏作为一个哨兵器官和一个遗传因子-NOS 2-作为线粒体周转和细胞存活的定量影响。我们计划测试这些特定的目的:目的1:通过定量NOS 2基因滴定研究确定NOS 2在严重脓毒症期间对肝线粒体生物合成和细胞存活的作用。1A.使用NOS 2滴定法确定NOx介导的mtDNA与蛋白质损伤、呼吸能力、高能代谢物水平和脓毒症诱导的肝细胞死亡之间的关系。1B.通过CREB和/或NRF-1诱导和NRF-21(GABPA)和/或PGC-11表达的调节,评估NOS 2表达对脓毒症中线粒体生物发生调节的重要性。目标二:了解脓毒症中肝脏AMPK激活与NOS 2、线粒体生物合成的转录程序和细胞凋亡的预防的关系。2A.确定NO依赖性AMPK激活是否通过CREB促进脓毒症中的线粒体生物合成和/或通过抑制促凋亡蛋白Bad和BNIP 3的磷酸化来防止凋亡。 2B.确定在脓毒症中AMPK的药理学激活是否可以独立于NOS 2促进线粒体生物合成和/或抑制细胞凋亡。 这些研究将为脓毒症中NOx诱导的线粒体损伤提供新的见解,即NOS 2调节线粒体生物合成的生理机制及其由AMPK协调的程度。通过暗示,NO调节AMPK将在MODS中发挥关键的挽救作用,并且这种知识将允许合理的新药理学方法来支持线粒体功能,同时最小化NOx的附带损伤。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CLAUDE A PIANTADOSI其他文献

CLAUDE A PIANTADOSI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CLAUDE A PIANTADOSI', 18)}}的其他基金

Respiration in Sepsis
脓毒症时的呼吸
  • 批准号:
    8436690
  • 财政年份:
    2013
  • 资助金额:
    $ 31.4万
  • 项目类别:
Respiration in Sepsis
脓毒症时的呼吸
  • 批准号:
    8666533
  • 财政年份:
    2013
  • 资助金额:
    $ 31.4万
  • 项目类别:
Respiration in Sepsis
脓毒症时的呼吸
  • 批准号:
    8971980
  • 财政年份:
    2013
  • 资助金额:
    $ 31.4万
  • 项目类别:
Redox Regulation of Lung Mitochondrial Biogenesis in Sepsis/Pneumonia
脓毒症/肺炎中肺线粒体生物发生的氧化还原调节
  • 批准号:
    8370970
  • 财政年份:
    2012
  • 资助金额:
    $ 31.4万
  • 项目类别:
Redox Regulation of Lung Mitochondrial Biogenesis in Sepsis/Pneumonia
脓毒症/肺炎中肺线粒体生物发生的氧化还原调节
  • 批准号:
    8462898
  • 财政年份:
    2012
  • 资助金额:
    $ 31.4万
  • 项目类别:
Redox Regulation of Lung Mitochondrial Biogenesis in Sepsis/Pneumonia
脓毒症/肺炎中肺线粒体生物发生的氧化还原调节
  • 批准号:
    8675191
  • 财政年份:
    2012
  • 资助金额:
    $ 31.4万
  • 项目类别:
Carbon Monoxide and Mitochondrial Quality Control in Sepsis-induced Lung Injury
脓毒症引起的肺损伤中的一氧化碳和线粒体质量控制
  • 批准号:
    8225578
  • 财政年份:
    2011
  • 资助金额:
    $ 31.4万
  • 项目类别:
Mitochondrial biogenesis in sepsis-induced organ dysfunction
脓毒症引起的器官功能障碍中的线粒体生物发生
  • 批准号:
    8217199
  • 财政年份:
    2009
  • 资助金额:
    $ 31.4万
  • 项目类别:
Mitochondrial biogenesis in sepsis-induced organ dysfunction
脓毒症引起的器官功能障碍中的线粒体生物发生
  • 批准号:
    8021807
  • 财政年份:
    2009
  • 资助金额:
    $ 31.4万
  • 项目类别:
Mitochondrial biogenesis in sepsis-induced organ dysfunction
脓毒症引起的器官功能障碍中的线粒体生物发生
  • 批准号:
    7782730
  • 财政年份:
    2009
  • 资助金额:
    $ 31.4万
  • 项目类别:

相似海外基金

Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
  • 批准号:
    2867610
  • 财政年份:
    2023
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
  • 批准号:
    BB/W009633/1
  • 财政年份:
    2022
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2021
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
  • 批准号:
    459043
  • 财政年份:
    2021
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2020
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10561642
  • 财政年份:
    2019
  • 资助金额:
    $ 31.4万
  • 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
  • 批准号:
    2243045
  • 财政年份:
    2019
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10359032
  • 财政年份:
    2019
  • 资助金额:
    $ 31.4万
  • 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
  • 批准号:
    428988
  • 财政年份:
    2019
  • 资助金额:
    $ 31.4万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了